1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NUTRAPLUS INDIA LTD.
Nutraplus India Ltd. BSE: 524764


Board Meetings - Nutraplus India Ltd.

The latest board meeting for Nutraplus India Ltd. took place on 09 Nov 2024, for the purpose of Quarterly Results

Ex-date Purpose Notes
09 Nov 2024 Quarterly Results -
01 Nov 2024 Quarterly Results -
26 Oct 2024 Quarterly Results -
19 Oct 2024 Quarterly Results -
18 Oct 2024 Quarterly Results -
16 Oct 2024 Quarterly Results for the quarter ended Jun, 2022
15 Oct 2024 Quarterly Results for the quarter ended Mar, 2022
14 Oct 2024 Quarterly Results for the quarter ended Dec, 2021
05 Oct 2024 Quarterly Results inter alia, to consider and approve the unaudited financial results of the company for the quarter ended September 30, 2021
04 Oct 2024 Quarterly Results inter alia, to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2021.
03 Oct 2024 Quarterly Results inter alia, to consider and approve the unaudited financial results of the company for the quarter ended March 31, 2021.
28 Sep 2024 Quarterly Results inter alia, to consider and approve the unaudited financial results of the company for the quarter ended September 30, 2020 and December 31, 2020.
21 Sep 2024 Quarterly Results inter alia, to consider and approve the unaudited financial results of the company for the quarter ended September 30, 2020.
14 Sep 2024 Quarterly Results inter alia, to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2020.
03 Oct 2020 Others Inter alia, to consider and approve the appointment of Mr. Mukesh D. Naik as an additional director of the company.
30 Jul 2020 Audited Results (Revised)
30 Jun 2020 Audited Results -
05 Mar 2020 Others inter alia, to consider and approve and discuss the notice dated 18th February, 2020 received from Saraswat Co-operative Bank Ltd, lender to the Company.
14 Feb 2020 Quarterly Results -
06 Jan 2020 Others inter alia, to consider and approve the Cost Audit Report for the financial year 2018-19 and take note of resignation of Non-Executive, Independent Director Mr. Prameshkumar B. Mehta of the Company
14 Nov 2019 Quarterly Results -
14 Aug 2019 Quarterly Results -
29 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Quarterly Results -
30 May 2018 Audited Results -
14 Feb 2018 Quarterly Results -
28 Nov 2017 Quarterly Results -
03 Nov 2017 To consider raising of funds The matters pertaining to raising of funds for the proposed Expansion Scheme by way of issue of warrants to Promoter and promoter group on preferential basis.
14 Sep 2017 Quarterly Results -
14 Aug 2017 Quarterly Results -
17 Jul 2017 Others 1)To review the status of Dahej project. 2)To consider the option to diversify into Agrochemical business.
30 May 2017 Audited Results -
30 Mar 2017 Others 1) Appointment of Mr. Nirad Mehta as a Additional Director (Non- executive & Independent category) with immediate effect and, who shall hold the office till the ensuing AGM of the Company.
14 Feb 2017 Quarterly Results -
14 Nov 2016 Quarterly Results -
26 Sep 2016 Appointment of an Additional Director -
22 Aug 2016 Bonus issue & Stock Split Revised
11 Aug 2016 Quarterly Results -
09 Aug 2016 Bonus issue & Stock Split -
01 Jul 2016 Others Inter alia, to consider cancellation and withdrawal of the scheme of Amalgamation of Vetpharma Limited (VPL) with the Company.
08 Jun 2016 Others To consider and approve draft of Management discussion and Analysis Report, Directors Report and Corporate Governance Report for the year ended March 31, 2016.
16 May 2016 Audited Results & Final Dividend -
02 May 2016 Audited Results -
30 Apr 2016 Others To Consider and approve the conversion of Warrants held by Mr. Uday Desai (Promoter) into equivalent number of Equity Shares.
12 Apr 2016 Others To Consider and approve the conversion of Warrants held by Mrs. Gita Naik into To Consider and approve the conversion of Warrants held by Mrs. Gita Naik into
30 Mar 2016 Others To Consider and approve the conversion of Warrants held by Mr. Mukesh Naik, Mr.Uday Desai and Mrs. Gita Naik into equivalent number of Equity Shares.
16 Feb 2016 Others To consider and approve setting up of new project through 100% subsidiary of the Company to be incorporated in India.
13 Feb 2016 Quarterly Results The Board has considered and approved the appointment of Mr. S. T. Dafle as the Company Secretary and Compliance Officer of the Company.
10 Nov 2015 Quarterly Results -
18 Sep 2015 Preferential Issue of Shares Subject to approval of shareholders to offer, issue and allot equity shares / warrants to Non promoters, on preferential basis.
14 Aug 2015 Quarterly Results Selling off the entire Stake from the wholly-owned subsidiary of the Company, i.e., Nutraplus Generic Medicines & Health Care Products Private Limited.
10 Jul 2015 Raising funds 1. Option of raising funds by way of issue of Securities for expansion schemes. 2. To get the Securities of Company Listed on National Stock Exchange.
19 Jun 2015 Others To discuss and issue guidelines for production and marketing of both the above said new facilities.
29 May 2015 Audited Results & Others Consider and approve the conversion of 800,000 Warrants held by Ms. Nidhi Naik into equivalent number of Equity Shares.
13 Feb 2015 Quarterly Results -
02 Jan 2015 Issue of Shares on Preferential Basis -
14 Nov 2014 Quarterly Results -
14 Aug 2014 Quarterly Results -
29 May 2014 Audited Results -
14 Feb 2014 Quarterly Results -
14 Nov 2013 Quarterly Results -
13 Aug 2013 Quarterly Results -
29 May 2013 Audited Results -
11 Feb 2013 Quarterly Results -
12 Nov 2012 Quarterly Results -
14 Aug 2012 Quarterly Results -
05 Jul 2012 Allotment of Equity shares & Warrants inter alia, lo consider the following business: Allotment of 4,00,000 Equity Shares and 3,00,000 Optionally Fully Convertible Warrants on preferential basis to the promoter of the Company
28 Apr 2012 To consider raising of funds Inter alia, to consider the Company's fund raising program by way of issue of Equity Shares / Warrants of preferential basis.
13 Feb 2012 Quarterly Results -
11 Nov 2011 Quarterly Results -
14 Oct 2011 Change in name of the Company To approve the postal ballot notice for change in the name of the Company from Nutraplus Products (India) Ltd. to Nutraplus India Ltd., subject to the approval of the Members of the Company.
11 Aug 2011 Quarterly Results & Others -
14 Jul 2011 Allotment of Equity Shares -
26 May 2011 Audited Results -
15 Feb 2011 Quarterly Results -
15 Nov 2010 Quarterly Results -
15 Oct 2010 Allotment of Equity Shares -
30 Jul 2010 Quarterly Results -
31 May 2010 Audited Results -
22 Mar 2010 Allotment of Equity Shares For allotment of 3,20,000 Equity Shares & 8,25,000 Optionally Fully Convertible Warrants on preferential basis to the Promoters and Persons/Entities of the Promoter Warrants on pref. basis to the Co.
15 Mar 2010 Others The BoD's has decided that the Company will not invest in the corporate bodies under the same management of the Company.
09 Feb 2010 Issue of Equity Shares / Conv. Warrants To issue of 3,20,000 Equity Shares & 8,25,000 CW's on preferential basis, at a price as determined in accordance with the SEBI (ICDR) Regulations, 2009 to Promoters / Promoters Group.
29 Jan 2010 Quarterly Results -
30 Oct 2009 Quarterly Results -
31 Jul 2009 Quarterly Results -
29 Jun 2009 Audited Results -
30 Apr 2009 Quarterly Results To publish audited financial results for the year ended March 31, 2009 on or before June 30, 2009.
30 Jan 2009 Quarterly Results -
24 Oct 2008 Quarterly Results -
31 Jul 2008 Quarterly Results -
30 Apr 2008 Quarterly Results -
31 Jan 2008 Quarterly Results -
31 Oct 2007 Quarterly Results -
31 Jul 2007 Audited Results & Quarterly Results -
30 Apr 2007 Quarterly Results -
31 Jan 2007 Quarterly Results -
31 Oct 2006 Quarterly Results -
31 Jul 2006 Acounts & Quarterly Results -